Organoiridium complexes: anticancer agents and catalysts

Z Liu, PJ Sadler - Accounts of Chemical Research, 2014 - ACS Publications
Conspectus Iridium is a relatively rare precious heavy metal, only slightly less dense than
osmium. Researchers have long recognized the catalytic properties of square-planar IrI …

Understanding cancer and the anticancer activities of naphthoquinones–a review

KW Wellington - RSC advances, 2015 - pubs.rsc.org
The non-communicable disease, cancer, is one of the major causes of death across the
world and is forecast to increase by 75% to reach close to 25 million cases over the next two …

Bioactive iridium and rhodium complexes as therapeutic agents

CH Leung, HJ Zhong, DSH Chan, DL Ma - Coordination Chemistry …, 2013 - Elsevier
Group 9 metal complexes based on iridium and rhodium have recently arisen as fascinating
potential alternatives to existing platinum and ruthenium metallodrugs. While long regarded …

Current status of iridium-based complexes against lung cancer

T Yang, M Zhu, M Jiang, F Yang, Z Zhang - Frontiers in Pharmacology, 2022 - frontiersin.org
Lung cancer is one of the most common malignant tumors, with the highest mortality rate in
the world, and its incidence is second only to breast cancer. It has posed a serious threat to …

Rhodium, iridium, and ruthenium half-sandwich picolinamide complexes as anticancer agents

Z Almodares, SJ Lucas, BD Crossley, AM Basri… - Inorganic …, 2014 - ACS Publications
Novel rhodium, iridium, and ruthenium half-sandwich complexes containing (N, N)-bound
picolinamide ligands have been prepared for use as anticancer agents. The complexes …

Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing CN-Chelated and Pyridine Ligands

Z Liu, I Romero-Canelón, A Habtemariam… - …, 2014 - ACS Publications
We report the synthesis and characterization of eight half-sandwich cyclopentadienyl IrIII
pyridine complexes of the type [(η5-Cpxph) Ir (phpy) Z] PF6, in which Cpxph= C5Me4C6H5 …

Iridium (III) complexes targeting apoptotic cell death in cancer cells

DL Ma, C Wu, KJ Wu, CH Leung - Molecules, 2019 - mdpi.com
Targeting apoptosis is a principal strategy in the design of anticancer drugs. In recent years,
non-platinum-based scaffolds have been exploited as viable candidates for the exploitation …

Contrasting anticancer activity of half-sandwich iridium (III) complexes bearing functionally diverse 2-phenylpyridine ligands

AJ Millett, A Habtemariam, I Romero-Canelón… - …, 2015 - ACS Publications
We report the synthesis, characterization, and antiproliferative activity of 15 iridium (III) half-
sandwich complexes of the type [(η5-Cp*) Ir (2-(R′-phenyl)-R-pyridine) Cl] bearing either …

Anticancer activity of iridium (III) complexes based on a pyrazole-appended quinoline-based BODIPY

RP Paitandi, S Mukhopadhyay, RS Singh… - Inorganic …, 2017 - ACS Publications
A pyrazole-appended quinoline-based 4, 4-difluoro-4-bora-3a, 4a-diaza-s-indacene (L1,
BODIPY) has been synthesized and used as a ligand for the preparation of iridium (III) …

Structurally strained half-sandwich iridium (III) complexes as highly potent anticancer agents

AC Carrasco, V Rodríguez-Fanjul… - Journal of Medicinal …, 2020 - ACS Publications
Six complexes of formula [Ir (η5: κ1-C5Me4CH2py)(C, N)] PF6, where C5Me4CH2py is 2-((2,
3, 4, 5-tetramethylcyclopentadienyl) methyl) pyridine, and C, N is 2-phenylpyridine (1), 7, 8 …